Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genome Diagnostics, Illumina Ink Cancer IVD Partnership

NEW YORK (GenomeWeb) – Personal Genome Diagnostics announced today that it has partnered with Illumina to develop two in vitro cancer diagnostics.

According to PGDx, the tests will be designed to detect and characterize tumor DNA from tissue or plasma samples, and will run on Illumina's sequencing instruments. Additional terms of the deal were not disclosed.

"PGDx currently offers advanced genomic testing services to researchers, drug developers, and physicians and patients through our CLIA-certified laboratory," CEO Doug Ward said in a statement. "We now want to apply our expertise to the development of IVD test kits for both tissue and plasma-based samples that will enable other laboratories with next-generation sequencing capability to benefit from our broad experience in cancer genomic testing."

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.